Sveriges mest populära poddar
The Journal.
NyheterDagliga nyheter

Novo Nordisk's CEO Has a Comeback Plan

22 min•26 maj 2026

When Maziar Mike Doustdar took over as CEO of Novo Nordisk last year, the company had lost ground in the anti-obesity drug market. Doustdar spoke with Jessica Mendoza about his plans to turn the company around, the recent success of their Wegovy pill and what keeps him up at night.

Further Listening:
- Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?

- Trillion Dollar Shot

Sign up for WSJ’s free What’s News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Fler avsnitt av The Journal.

Visa alla avsnitt av The Journal.
The Booming Industry Keeping Taylor Swift's Wedding a Secret
•21 min
Microsoft’s CEO Has a Message: Don’t Let AI Eat the Economy
•21 min
The Supreme Court and Trump: From Birthright to Presidential Power
•20 min
Weight-Loss Drugs Are Gobbling Up Small Town Budgets
•19 min
Inside a Debate at OpenAI Over Mass Shootings
•37 min
McDonald’s and Coke's Marriage Might Need a Refresher
•20 min
Why Alan Greenspan Is Key to Understanding Today’s Fed
•22 min
Inside Trump and Netanyahu’s Complicated Relationship
•20 min
Why iPhones Will Probably Get Even More Expensive
•18 min
The Big Business of Holding Back Eighth-Graders
•24 min

The Journal. med The Wall Street Journal & Spotify Studios finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.